BioNTech SE
BNTX
$97.27
$4.504.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 192.37M | 1.27B | 1.37B | 138.52M | 203.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 192.37M | 1.27B | 1.37B | 138.52M | 203.66M |
| Cost of Revenue | 88.19M | 259.56M | 196.68M | 64.36M | 64.16M |
| Gross Profit | 104.18M | 1.01B | 1.17B | 74.16M | 139.50M |
| SG&A Expenses | 126.91M | 140.81M | 165.46M | 197.83M | 143.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -55.56M | 47.01M | 378.41M | 282.32M | -9.23M |
| Total Operating Expenses | 712.65M | 1.10B | 1.35B | 1.17B | 749.81M |
| Operating Income | -520.28M | 168.96M | 22.98M | -1.04B | -546.16M |
| Income Before Tax | -468.71M | 321.07M | 174.47M | -867.31M | -360.20M |
| Income Tax Expenses | -31.15M | 44.45M | -43.32M | 2.15M | -18.13M |
| Earnings from Continuing Operations | -437.57M | 276.62M | 217.79M | -869.46M | -342.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -437.57M | 276.62M | 217.79M | -869.46M | -342.07M |
| EBIT | -520.28M | 168.96M | 22.98M | -1.04B | -546.16M |
| EBITDA | -475.24M | 296.66M | 71.79M | -981.51M | -504.58M |
| EPS Basic | -1.82 | 1.15 | 0.90 | -3.62 | -1.42 |
| Normalized Basic EPS | -1.15 | 0.92 | 0.57 | -2.19 | -0.88 |
| EPS Diluted | -1.82 | 1.15 | 0.89 | -3.62 | -1.42 |
| Normalized Diluted EPS | -1.15 | 0.92 | 0.56 | -2.19 | -0.88 |
| Average Basic Shares Outstanding | 240.35M | 240.28M | 241.59M | 240.42M | 240.53M |
| Average Diluted Shares Outstanding | 240.35M | 240.28M | 244.57M | 240.42M | 240.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |